Below are the most recent publications written about "Hydrogen Bonding" by people in Profiles.
-
Alleyne T, Ignacio DN, Sampson VB, Ashe D, Wilson M. Simulating the slow to fast switch in cytochrome c oxidase catalysis by introducing a loop flip near the enzyme's cytochrome c (substrate) binding site. Biotechnol Appl Biochem. 2017 Sep; 64(5):677-685.
-
Hashimoto H, Wang D, Horton JR, Zhang X, Corces VG, Cheng X. Structural Basis for the Versatile and Methylation-Dependent Binding of CTCF to DNA. Mol Cell. 2017 Jun 01; 66(5):711-720.e3.
-
Patel PA, Kvaratskhelia N, Mansour Y, Antwi J, Feng L, Koneru P, Kobe MJ, Jena N, Shi G, Mohamed MS, Li C, Kessl JJ, Fuchs JR. Indole-based allosteric inhibitors of HIV-1 integrase. Bioorg Med Chem Lett. 2016 10 01; 26(19):4748-4752.
-
Moise G, Gallup NM, Alexandrova AN, Hengge AC, Johnson SJ. Conservative tryptophan mutants of the protein tyrosine phosphatase YopH exhibit impaired WPD-loop function and crystallize with divanadate esters in their active sites. Biochemistry. 2015 Oct 27; 54(42):6490-500.
-
Woll KA, Weiser BP, Liang Q, Meng T, McKinstry-Wu A, Pinch B, Dailey WP, Gao WD, Covarrubias M, Eckenhoff RG. Role for the propofol hydroxyl in anesthetic protein target molecular recognition. ACS Chem Neurosci. 2015 Jun 17; 6(6):927-35.
-
Bresler SC, Weiser DA, Huwe PJ, Park JH, Krytska K, Ryles H, Laudenslager M, Rappaport EF, Wood AC, McGrady PW, Hogarty MD, London WB, Radhakrishnan R, Lemmon MA, Mossé YP. ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma. Cancer Cell. 2014 Nov 10; 26(5):682-94.
-
Singh P, Aggarwal S, Tiwari AK, Kumar V, Pratap R, Chuttani K, Mishra AK. Bis(methylpyridine)-EDTA derivative as a potential ligand for PET imaging: synthesis, complexation, and biological evaluation. Chem Biol Drug Des. 2014 Dec; 84(6):704-11.
-
Hashimoto H, Pais JE, Zhang X, Saleh L, Fu ZQ, Dai N, Corr?a IR, Zheng Y, Cheng X. Structure of a Naegleria Tet-like dioxygenase in complex with 5-methylcytosine DNA. Nature. 2014 Feb 20; 506(7488):391-5.
-
Poelarends GJ, Serrano H, Huddleston JP, Johnson WH, Whitman CP. A mutational analysis of active site residues in trans-3-chloroacrylic acid dehalogenase. FEBS Lett. 2013 Sep 02; 587(17):2842-50.
-
Rahaman O, van Duin AC, Goddard WA, Doren DJ. Development of a ReaxFF reactive force field for glycine and application to solvent effect and tautomerization. J Phys Chem B. 2011 Jan 20; 115(2):249-61.